Pancreatic cancer screening for people at high genetic risk
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a strong family history of pancreatic cancer, or a known inherited gene mutation (like BRCA1, BRCA2, ATM, PALB2, or others) plus a close family member with pancreatic cancer
- You are either age 50 or younger than the youngest relative who had pancreatic cancer
- Your overall health allows normal activities (performance status 0 to 1)
- You can safely have an MRI, including having gadolinium contrast if needed, and you have no MRI/contrast restrictions
- Your kidney function is sufficient (eGFR greater than 29)
- You agree to consent and return to the study site for required visits and tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether regular imaging can find pancreatic cancer earlier in people who recently developed diabetes or whose diabetes is getting worse. It may help detect pancreatic problems sooner when treatment options are likely better.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.
This study looks at how to screen the pancreas in people who are at increased risk for pancreatic cancer, using a set of risk guidelines. Screening may help find cancer (or early changes) sooner, when it may be easier to treat.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.